Jaffetilchin Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.43M | Buy |
4,078
+74
| +2% | +$26.4K | 0.09% | 154 |
|
|
2025
Q4 | $1.31M | Buy |
4,004
+4
| +0.1% | +$1.27K | 0.08% | 162 |
|
|
2025
Q3 | $1.13M | Sell |
4,000
-95
| -2% | -$27.6K | 0.07% | 178 |
|
|
2025
Q2 | $1.14M | Sell |
4,095
-1,262
| -24% | -$358K | 0.07% | 164 |
|
|
2025
Q1 | $1.67M | Buy |
5,357
+1,397
| +35% | +$413K | 0.12% | 125 |
|
|
2024
Q4 | $1.03M | Buy |
3,960
+1,775
| +81% | +$527K | 0.07% | 160 |
|
|
2024
Q3 | $704K | Buy |
2,185
+309
| +16% | +$101K | 0.05% | 187 |
|
|
2024
Q2 | $586K | Buy |
1,876
+42
| +2% | +$12.3K | 0.05% | 195 |
|
|
2024
Q1 | $521K | Sell |
1,834
-2,145
| -54% | -$628K | 0.05% | 203 |
|
|
2023
Q4 | $1.15M | Buy |
3,979
+182
| +5% | +$49.6K | 0.11% | 120 |
|
|
2023
Q3 | $1.02M | Buy |
3,797
+2,085
| +122% | +$520K | 0.11% | 115 |
|
|
2023
Q2 | $380K | Sell |
1,712
-268
| -14% | -$62.2K | 0.04% | 239 |
|
|
2023
Q1 | $479K | Buy |
1,980
+1,101
| +125% | +$270K | 0.05% | 208 |
|
|
2022
Q4 | $231K | Buy |
+879
| New | +$236K | 0.03% | 317 |
|
|
2022
Q3 | – | Sell |
-3,724
| Closed | -$906K | – | 315 |
|
|
2022
Q2 | $906K | Buy |
3,724
+52
| +1% | +$12.7K | 0.11% | 129 |
|
|
2022
Q1 | $898K | Buy |
3,672
+1,736
| +90% | +$399K | 0.11% | 127 |
|
|
2021
Q4 | $436K | Buy |
1,936
+564
| +41% | +$119K | 0.04% | 231 |
|
|
2021
Q3 | $292K | Buy |
1,372
+112
| +9% | +$25.8K | 0.03% | 279 |
|
|
2021
Q2 | $307K | Sell |
1,260
-991
| -44% | -$244K | 0.02% | 322 |
|
|
2021
Q1 | $560K | Sell |
2,251
-370
| -14% | -$88.3K | 0.07% | 187 |
|
|
2020
Q4 | $603K | Buy |
2,621
+76
| +3% | +$17.5K | 0.09% | 147 |
|
|
2020
Q3 | $647K | Buy |
2,545
+230
| +10% | +$57K | 0.12% | 102 |
|
|
2020
Q2 | $546K | Buy |
+2,315
| New | +$528K | 0.12% | 105 |
|
|
2018
Q4 | – | Sell |
-1,586
| Closed | -$329K | – | 259 |
|
|
2018
Q3 | $329K | Buy |
1,586
+60
| +4% | +$11.8K | 0.07% | 217 |
|
|
2018
Q2 | $282K | Buy |
+1,526
| New | +$270K | 0.06% | 233 |
|
|
2017
Q4 | – | Sell |
-3,621
| Closed | -$675K | – | 229 |
|
|
2017
Q3 | $675K | Buy |
+3,621
| New | +$642K | 0.16% | 113 |
|
|
2017
Q2 | – | Sell |
-3,909
| Closed | -$641K | – | 222 |
|
|
2017
Q1 | $641K | Buy |
3,909
+508
| +15% | +$84.4K | 0.16% | 102 |
|
|
2016
Q4 | $497K | Buy |
3,401
+946
| +39% | +$142K | 0.15% | 118 |
|
|
2016
Q3 | $410K | Buy |
2,455
+896
| +57% | +$152K | 0.13% | 125 |
|
|
2016
Q2 | $237K | Sell |
1,559
-1,145
| -42% | -$178K | 0.07% | 192 |
|
|
2016
Q1 | $405K | Buy |
+2,704
| New | +$402K | 0.13% | 104 |
|
|
2015
Q4 | – | Sell |
-2,350
| Closed | -$325K | – | 186 |
|
|
2015
Q3 | $325K | Buy |
2,350
+4
| +0.2% | +$631 | 0.12% | 131 |
|
|
2015
Q2 | $360K | Buy |
2,346
+11
| +0.5% | +$1.76K | 0.11% | 144 |
|
|
2015
Q1 | $373K | Sell |
2,335
-2,720
| -54% | -$428K | 0.11% | 141 |
|
|
2014
Q4 | $805K | Buy |
5,055
+2,443
| +94% | +$381K | 0.27% | 61 |
|
|
2014
Q3 | $367K | Buy |
2,612
+3
| +0.1% | +$392 | 0.13% | 129 |
|
|
2014
Q2 | $309K | Buy |
2,609
+4
| +0.2% | +$463 | 0.11% | 168 |
|
|
2014
Q1 | $321K | Buy |
2,605
+3
| +0.1% | +$364 | 0.13% | 144 |
|
|
2013
Q4 | $297K | Buy |
2,602
+38
| +1% | +$4.32K | 0.15% | 148 |
|
|
2013
Q3 | $287K | Hold |
2,564
| – | – | 0.17% | 131 |
|
|
2013
Q2 | $253K | Buy |
+2,564
| New | +$266K | 0.18% | 152 |
|
Other funds holding AMGN
VCM
VPM
Jaffetilchin Investment Partners's AMGN Position: Q1 2026 in Review
Jaffetilchin Investment Partners increased its Amgen (AMGN) stake by 1.8% in Q1 2026, buying an estimated $26.4K and bringing the position to 4,078 shares worth $1.43M. The position accounts for 0.09% of the portfolio, ranked #154.
Jaffetilchin Investment Partners first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.67M in Q1 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Jaffetilchin Investment Partners held 4,078 shares of Amgen worth $1.43M as of Q1 2026.
- Jaffetilchin Investment Partners bought 74 Amgen shares in Q1 2026, an estimated $26.4K.
- Amgen made up 0.09% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #154 holding.
- Jaffetilchin Investment Partners first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
- Jaffetilchin Investment Partners's Amgen position peaked at $1.67M in Q1 2025.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.